Sign inGet started

Le Goff Corinne

Insider CIK 1840912 · MRNA Chief Commercial Officer · VTRS Chief Commercial Officer · LBPH Director · CLSN President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VTRS Viatris Inc M Exercise deriv2026-04-152026-04-1639,344— $00SEC↗
VTRS Viatris Inc M Exercise deriv2026-04-152026-04-163,644— $00SEC↗
VTRS Viatris Inc M Exercise2026-04-152026-04-163,644— $0108,752SEC↗
VTRS Viatris Inc M Exercise2026-04-152026-04-1639,344— $0122,558SEC↗
VTRS Viatris Inc F Tax w/h2026-04-152026-04-1617,450$13.86 $241.9K105,108SEC↗
VTRS Viatris Inc F Tax w/h2026-04-152026-04-161,617$13.86 $22.4K107,135SEC↗
VTRS Viatris Inc A Award deriv2026-03-062026-03-1088,984— $088,984SEC↗
VTRS Viatris Inc M Exercise deriv2026-03-062026-03-1044,165— $088,328SEC↗
VTRS Viatris Inc M Exercise deriv2026-03-062026-03-102,192— $04,385SEC↗
VTRS Viatris Inc F Tax w/h2026-03-062026-03-10973$14.16 $13.8K83,214SEC↗
VTRS Viatris Inc F Tax w/h2026-03-062026-03-1019,588$14.16 $277.4K81,994SEC↗
VTRS Viatris Inc M Exercise2026-03-062026-03-102,193— $084,187SEC↗
VTRS Viatris Inc M Exercise2026-03-062026-03-1044,165— $0101,582SEC↗
VTRS Viatris Inc M Exercise deriv2026-03-042026-03-053,053— $03,053SEC↗
VTRS Viatris Inc M Exercise deriv2026-03-042026-03-0536,720— $036,721SEC↗
VTRS Viatris Inc F Tax w/h2026-03-042026-03-051,355$14.71 $19.9K57,417SEC↗
VTRS Viatris Inc M Exercise2026-03-042026-03-053,053— $058,772SEC↗
VTRS Viatris Inc F Tax w/h2026-03-042026-03-0516,300$14.71 $239.8K55,719SEC↗
VTRS Viatris Inc M Exercise2026-03-042026-03-0536,720— $072,019SEC↗
VTRS Viatris Inc S Sale2025-09-112025-09-127,032$10.25 $72.1K35,299SEC↗
VTRS Viatris Inc M Exercise deriv2025-04-152025-04-1639,344— $039,344SEC↗
VTRS Viatris Inc M Exercise deriv2025-04-152025-04-161,768— $01,768SEC↗
VTRS Viatris Inc M Exercise2025-04-152025-04-1639,344— $060,441SEC↗
VTRS Viatris Inc F Tax w/h2025-04-152025-04-1619,023$7.48 $142.3K41,418SEC↗
VTRS Viatris Inc M Exercise2025-04-152025-04-161,768— $043,186SEC↗
VTRS Viatris Inc F Tax w/h2025-04-152025-04-16855$7.48 $6.4K42,331SEC↗
VTRS Viatris Inc A Award deriv2025-03-062025-03-10132,493— $0132,493SEC↗
VTRS Viatris Inc M Exercise deriv2025-03-042025-03-0536,721— $073,441SEC↗
VTRS Viatris Inc M Exercise deriv2025-03-042025-03-051,173— $02,344SEC↗
VTRS Viatris Inc F Tax w/h2025-03-042025-03-05521$9.37 $4.9K21,097SEC↗
VTRS Viatris Inc F Tax w/h2025-03-042025-03-0516,276$9.37 $152.5K20,445SEC↗
VTRS Viatris Inc M Exercise2025-03-042025-03-0536,721— $036,721SEC↗
VTRS Viatris Inc M Exercise2025-03-042025-03-051,173— $021,618SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0222,500— $00SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0212,500— $00SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
LBPH Longboard Pharmaceuticals, D To issuer deriv2024-12-022024-12-0213,397— $00SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2024-05-232024-05-2422,500— $022,500SEC↗
VTRS Viatris Inc A Award deriv2024-04-182024-04-19110,162— $0110,162SEC↗
VTRS Viatris Inc A Award deriv2024-04-182024-04-1978,688— $078,688SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2023-05-252023-05-2612,500— $012,500SEC↗
IMNN Imunon, Inc. A Award deriv2023-03-172023-03-2190,000— $0320,000SEC↗
CLSN Celsion CORP A Award deriv2022-07-182022-07-20177,000— $0177,000SEC↗
CLSN Celsion CORP A Award2022-07-182022-07-2053,000— $053,000SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2022-05-242022-05-3112,367— $012,367SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2021-03-112021-03-1112,367— $012,367SEC↗
LBPH Longboard Pharmaceuticals, A Award deriv2021-03-112021-03-1113,397— $013,397SEC↗
MRNA Moderna, Inc. A Award deriv2021-02-012021-02-0258,563— $058,563SEC↗
MRNA Moderna, Inc. A Award deriv2021-02-012021-02-0225,400— $025,400SEC↗